©The Author(s) 2025.
World J Gastrointest Surg. Oct 27, 2025; 17(10): 111885
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.111885
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.111885
Table 3 Nephrotoxicity data and distribution by chemotherapy agent, n (%)
| Variable | Total (N = 445) | Cisplatin (n = 126) | Other agents (n = 319) | P value |
| AKI incidence | 61 (13.7) | 27 (21.4) | 34 (10.6) | 0.005 |
| AKI stage 1/2/3 | 38/15/8 | 18/6/3 | 20/9/5 | 0.839 |
| Development of CKD | 5 (1.1) | 3 (2.4) | 2 (0.6) | 0.154 |
- Citation: Göksu Ş, Düzgün Ö. Perioperative approach to nephrotoxicity in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Gastrointest Surg 2025; 17(10): 111885
- URL: https://www.wjgnet.com/1948-9366/full/v17/i10/111885.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i10.111885